Association between angiotensin-converting enzyme and Alzheimer disease

Archives of Neurology

Volumn 57, Issue 2, 2000, Pages 210-214

  Farrer, Lindsay A ^a   Shcrbatich, Tatyana ^a   Kcryanov, Scrgcy A ^a   Korovaitscva, Galina I ^a   Rogaeva, Ehatcrina A ^a   Petruk, Svetlana ^a   Premkumar, Smita ^a   Moliaha, Yuri ^a   Song, You Qiang ^a   Pei, York ^a   Sato, Christine ^a   Selczncva, Natalya D ^a   Voshresenshaya, Svetlana ^a   Golimbct, Vera ^a   Sorbi, Sandra ^a   Duara, Rangcnc ^a   Gavrilova, Svetlana ^a   St Georgc Hyslop, Peter H ^a   Rogaev, Evgeny L ^a  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 12944310975     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.2.210     Document Type: Article

References (39)

1. Farrer LA, Myers RH, Connor L, Cupples LA, Growdon JH. Segregation analysis reveals evidence of a major gene for Alzheimer disease. Am J Hum Genet. 1991;48:1026-1033.
2. Goate A, Chartier-Harlin M-C, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Hatore. 1991;349:704-706.
3. Sherrington R, Rogaev El, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995;375:754-760.
4. Rogaev EI, Sherrington R, Rogaeva EA, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995;376:775-778.
5. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995;269:973-977.
6. Farrer LA. Genetics and the dementia patient. Neurologist. 1997;3:13-30.
7. Nalbantoglu J, Gilfix BM, Bertrand P, et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol. 1994;36:889-895.
8. Roses AD, Devlin B, Conneally PM, et al. Measuring the genetic contribution of APOE in late-onset Alzheimer disease (AD) [abstract]. Am J Hum Genet. 1995;57:A202.
9. Soffer RL. Angiotensin-converting enzyme and the regulation of vasoactive peptides. Ann Rev Biochem. 1976;45:73-94.
10. Arregui A, MacKay AVP, Spokes EG, Iversen LL. Reduced activity of angiotensinconverting enzyme in basal ganglia in early-onset schizophrenia. Psychol Med. 1980;10:307-313.
11. Arregui A, Bennett JP, Bird ED, Yamamura HI, Iversen LL, Snyder SH. Huntington's chorea: selected depletion of activity of angiotensin-converting enzyme in the corpus striatum. Ann Neurol. 1977;2:294-298.
12. Arregui A, Perry EK, Rossor M, Tomlinson BE. Angiotensin-converting enzyme in Alzheimer's disease: increased activity in caudate nucleus and cortical areas. J Neurochem. 1982;38:1490-1492.
13. Rinne UK, Koskinen V, Laaksonen H, Tex O. Angiotensin-converting enzyme in the Parkinson's brain. Ann Neurol. 1978;4:483.
14. Zubenko GS, Volicer L, Direnfeld LK, Freeman M, Langlais P, Nixon R. Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy. Brain Res. 1985;328:215-222.
15. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
16. Tiret L, Kee F, Poirier O, et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet. 1993;341:991-992.
17. Beohar N, Damaraju S, Prather A, et al. Angiotensin-1 converting enzyme genotype DD is a risk factor for CAD. J Invest Med. 1995;43:275-280.
18. Margaglione M, Celentano E, Grandone E, et al. Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol. 1996;16:2304-2309.
19. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and expression of Alzheimer disease: the Nun Study. JAMA. 1997;277:813-817.
20. World Health Organization. International Statistical Classification of Diseases, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization; 1992.
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-945.
22. El'chinneva GL, Mamedova RA, Brusintseva 0V, Ginter EK. Comparison of several Russian populations by vital statistics and frequency of genes causing hereditary pathology. Genetika. 1994;30:1558-1559.
23. Rogaeva E, Premkumar S, Grubber J, et al. A comprehensive examination of an α-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat Genet. 1999;21:19-21.
24. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337:1158-1159.
25. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992;20:1433.
26. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol 1: The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer; 1980.1 ARC scientific publication 32.
27. Kehoe PG, Russ C, Mcllroy S, et al. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet. 1999;21:71-72.
28. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, gender and ethnicity on the association of apolipoprotein E genotype and Alzheimer disease. JAMA. 1997;278:1349-1356.
29. Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early- and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 1994;3:569-574.
30. Okuizumi K, Onodera'O, Tanaka H, et al. ApoE-ε4 and early-onset Alzheimer's. Nat Genet. 1994;7:10-11.
31. Rebeck GW, Peris TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apoli-poprotein ε4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology. 1994;44:1513-1516.
32. van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a populationbased study of early-onset Alzheimer's disease. Nat Genet. 1994;7:74-78.
33. Corder EH, Basun H, Lannfelt L, Vitanen M, Winblad B. Attenuation of apolipoprotein E ε4 allele gene dose in late age [letter]. Lancet. 1996;347:542.
34. Tysoe C, Galinsky D, Robinson D, et al. Analysis of α-1 antichymotrypsin, presenilin-1, angiotensin-converting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia. Am J Med Genet. 1997;74:207-212.
35. Chapman J, Wang N, Treves TA, Korczyn AD, Bornstein NM. ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke. 1998;29:1401-1404.
36. Doi Y, Yoshinari M, Yoshizumi H, Ibayashi S, Wakisaka M, Fujishima M. Polymorphism of the angiotensin-converting enzyme (ACE) gene in patients with thrombotic brain infarction. Atherosclerosis. 1997;132:2145-2150.
37. Rigat B, Hubert CV, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
38. Schächter F, Faure-Delanef L, Guénot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994;6:29-32.
39. Galinsky D, Tysoe C, Brayne CE, et al. Analysis of the apo E/apo C-1, angiotensin converting enzyme and methylenetetrahydro-folate reductase genes as candidates affecting human longevity. Atherosclerosis. 1997;129:177-183.